Key result
Deep mutational scanning identifies a conserved druggable 2C helicase pocket as a pan-enterovirus therapeutic target.
Why the study?
Deep mutational scanning analyses do not discern type-specific from species-level constraints, limiting their utility in understanding how selective pressures change as viral families diversify.
Comparative deep mutational scanning of enteroviruses identifies conserved evolutionary constraints in core enzymatic machinery, providing a framework for designing broad-spectrum therapeutics.
Should not yet change clinical practice; leaves open new targets for broad-spectrum enterovirus antivirals.
Deep mutational scanning (DMS) can define functional constraints acting on viral proteomes by quantifying the effects of mutations on viral fitness. However, DMS analyses do not discern type-specific from species-level constraints, limiting their utility in understanding how selective pressures change as viral families diversify. Here we show that comparison of DMS datasets from related viruses can overcome these limitations. By contrasting two proteome-wide DMS datasets from prototypical members of the enterovirus A and B species, we identify evolutionary constraints at the species level to occur across core enzymatic machinery and capsid assembly interfaces. In contrast, type-level constraints are observed across host-interaction sites in both structural and non-structural proteins. Furthermore, we find DMS data to reflect both type- and species-level evolutionary signatures in nature yet diverge at conserved hotspots subjected to selection pressures that are lacking in vitro. Finally, we highlight the utility of comparative DMS studies for drug discovery by identifying a mutationally constrained pocket in the 2C helicase that is conserved across all major human enterovirus species. Our findings provide a framework for dissecting evolutionary pressures acting at different evolutionary scales and for guiding the rational design of broad-spectrum therapeutics with high barriers to resistance.
No takes yet. Share an insight, caveat, or question.
Álvarez-Rodríguez et al. (2026) studied Enterovirus infection. Comparative deep mutational scanning of enteroviruses A and B identified a highly conserved, mutationally constrained druggable pocket in the 2C helicase as a pan-enterovirus therapeutic target.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: